pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'keynote 671']
keynote 671 . allowed egfr and alk mutated pts . allowed radiotherapy to some of the pts. will it make difference in interpretation of outcomes? #asco23
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists